These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 37776482)
21. Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis. Yoshii I; Sawada N; Chijiwa T Rheumatol Int; 2022 Nov; 42(11):1947-1954. PubMed ID: 35410410 [TBL] [Abstract][Full Text] [Related]
22. Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Watanabe R; Ebina K; Gon T; Okano T; Murata K; Murakami K; Maeda Y; Jinno S; Shirasugi I; Son Y; Amuro H; Katayama M; Hara R; Hata K; Yoshikawa A; Yamamoto W; Tachibana S; Hayashi S; Etani Y; Katsushima M; Fukumoto K; Yamada S; Hashimoto M Rheumatology (Oxford); 2024 Sep; 63(9):2418-2426. PubMed ID: 38724245 [TBL] [Abstract][Full Text] [Related]
23. Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations. Garcia-Salinas R; Sanchez-Prado E; Mareco J; Ronald P; Ruta S; Gomez R; Magri S Rheumatol Int; 2023 Oct; 43(10):1821-1828. PubMed ID: 37269430 [TBL] [Abstract][Full Text] [Related]
24. EULAR definition of difficult-to-treat rheumatoid arthritis. Nagy G; Roodenrijs NMT; Welsing PM; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Blaas E; Senolt L; Szekanecz Z; Choy E; Dougados M; Jacobs JW; Geenen R; Bijlsma HW; Zink A; Aletaha D; Schoneveld L; van Riel P; Gutermann L; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM Ann Rheum Dis; 2021 Jan; 80(1):31-35. PubMed ID: 33004335 [TBL] [Abstract][Full Text] [Related]
25. Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. David P; Di Matteo A; Hen O; Dass S; Marzo-Ortega H; Wakefield RJ; Bissell LA; Nam J; Mankia K; Emery P; Saleem B; McGonagle D Arthritis Rheumatol; 2024 Apr; 76(4):510-521. PubMed ID: 38059326 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. Roodenrijs NMT; Hamar A; Kedves M; Nagy G; van Laar JM; van der Heijde D; Welsing PMJ RMD Open; 2021 Jan; 7(1):. PubMed ID: 33419871 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice. Takanashi S; Kaneko Y; Takeuchi T Rheumatology (Oxford); 2021 Nov; 60(11):5247-5256. PubMed ID: 33682890 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort. Watanabe R; Hashimoto M; Murata K; Murakami K; Tanaka M; Ohmura K; Ito H; Matsuda S Immunol Med; 2022 Mar; 45(1):35-44. PubMed ID: 34033729 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. Roodenrijs NMT; Kedves M; Hamar A; Nagy G; van Laar JM; van der Heijde D; Welsing PMJ RMD Open; 2021 Jan; 7(1):. PubMed ID: 33514671 [TBL] [Abstract][Full Text] [Related]
30. Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study. Michitsuji T; Fukui S; Morimoto S; Endo Y; Nishino A; Nishihata S; Tsuji Y; Shimizu T; Umeda M; Sumiyoshi R; Koga T; Iwamoto N; Origuchi T; Ueki Y; Yoshitama T; Eiraku N; Matsuoka N; Okada A; Fujikawa K; Ohtsubo H; Takaoka H; Hamada H; Tsuru T; Nawata M; Arinobu Y; Hidaka T; Tada Y; Kawakami A; Kawashiri SY Scand J Rheumatol; 2024 Mar; 53(2):123-129. PubMed ID: 38085537 [TBL] [Abstract][Full Text] [Related]
31. Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat. Ekin A; Misirci S; Görünen A; Coskun BN; Yagiz B; Dalkilic E; Pehlivan Y Med Princ Pract; 2024 Sep; ():1-12. PubMed ID: 39288740 [TBL] [Abstract][Full Text] [Related]
32. Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon. Messelink MA; Roodenrijs NMT; van Es B; Hulsbergen-Veelken CAR; Jong S; Overmars LM; Reteig LC; Tan SC; Tauber T; van Laar JM; Welsing PMJ; Haitjema S Arthritis Res Ther; 2021 Jul; 23(1):184. PubMed ID: 34238346 [TBL] [Abstract][Full Text] [Related]
33. Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn? Hofman ZLM; Roodenrijs NMT; Nikiphorou E; Kent AL; Nagy G; Welsing PMJ; van Laar JM Rheumatology (Oxford); 2024 Oct; ():. PubMed ID: 39383505 [TBL] [Abstract][Full Text] [Related]
34. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. Bertsias A; Flouri ID; Repa A; Avgoustidis N; Kalogiannaki E; Pitsigavdaki S; Bertsias G; Sidiropoulos P RMD Open; 2024 Jan; 10(1):. PubMed ID: 38242549 [TBL] [Abstract][Full Text] [Related]
35. Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis. McDermott GC; DiIorio M; Kawano Y; Jeffway M; MacVicar M; Dahal K; Moon SJ; Seyok T; Coblyn J; Massarotti E; Weinblatt ME; Weisenfeld D; Liao KP Semin Arthritis Rheum; 2024 Jun; 66():152421. PubMed ID: 38457949 [TBL] [Abstract][Full Text] [Related]
36. Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin? Dey M; Nagy G; Nikiphorou E Rheumatology (Oxford); 2023 May; 62(5):1773-1779. PubMed ID: 36205537 [TBL] [Abstract][Full Text] [Related]
37. Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis. Takanashi S; Takeuchi T; Kaneko Y Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38851883 [TBL] [Abstract][Full Text] [Related]
38. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906 [TBL] [Abstract][Full Text] [Related]
39. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search. Roodenrijs NMT; Welsing PMJ; van Roon J; Schoneveld JLM; van der Goes MC; Nagy G; Townsend MJ; van Laar JM Rheumatology (Oxford); 2022 Aug; 61(9):3552-3566. PubMed ID: 35238332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]